We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Legal & General Global Healthcare & Pharmaceutical Class C - Income (GBP)

Sell:71.71p Buy:71.71p Change: 0.08p (0.11%)
Prices as at 20 March 2026
Sell:71.71p
Buy:71.71p
Change: 0.08p (0.11%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 20 March 2026
Sell:71.71p
Buy:71.71p
Change: 0.08p (0.11%)
Prices as at 20 March 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 92.69%
UK Equities 6.40%
Cash and Equiv. 0.91%
Mutual Funds 0.00%
Alternative Trading Strategies 0.00%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 10.17% USA Pharmaceuticals & Biotechnology
2 JOHNSON & JOHNSON 7.22% USA Pharmaceuticals & Biotechnology
3 ABBVIE 4.95% USA Pharmaceuticals & Biotechnology
4 ROCHE HOLDING AG 4.23% CHE Pharmaceuticals & Biotechnology
5 NOVARTIS AG 4.01% CHE Pharmaceuticals & Biotechnology
6 MERCK & CO INC(NEW) 3.76% USA Pharmaceuticals & Biotechnology
7 ASTRAZENECA 3.37% GBR Pharmaceuticals & Biotechnology
8 UNITEDHEALTH GROUP INCORPORATED 3.19% USA Health Care Providers
9 AMGEN 2.54% USA Pharmaceuticals & Biotechnology
10 ABBOTT LABORATORIES 2.47% USA Medical Equipment & Services

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account